Kalvista Pharmaceuticals Inc (KALV)
CapEx to Revenue
0.26%
Quarterly · Period ending:
KALV CapEx to Revenue
Latest reported0.26%period ending
Latest reported0.26%period ending
KALV Quarterly CapEx/Revenue (0.25% → 0.26%)
Latest values, visible window
High-resolution chart · PNG
KALV capex to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | CapEx to Revenue |
|---|---|
| 0.2603% | |
| 0.2961% | |
| 0.1753% | |
| 20.3366% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0.2092% | |
| 0% | |
| 2.9082% | |
| 2.9089% | |
| 9.3985% | |
| 0.5141% | |
| 3.9521% | |
| 15.1963% | |
| 22.3967% | |
| 7.8078% | |
| 4.5253% | |
| 114.5833% | |
| 6.1404% | |
| 0.0024% | |
| 0% | |
| 871.4286% | |
| 2,628.5714% | |
| 13,675% | |
| 300% | |
| 1,128.5714% | |
| 2,571.4286% | |
| 950% | |
| 70% | |
| 1,500% | |
| 16.6667% | |
| 0.2513% |